BD-001(BindeBio)

N/A

Report date: 2025/03/03 17:00:02

Base Information

Drug NameBD-001(BindeBio)

Drug Alias NameBD-001BD001

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaIND

Originator CompaniesShenzhen Bindebio Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShenzhen Bindebio Ltd

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A